Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Perspective
Nature Reviews Cancer 5, 397–405 (1 May 2005) | doi:10.1038/nrc1613
Immunotherapy and chemotherapy |[mdash]| a practical partnership
&
Abstract
This article discusses how recent data have altered the way we understand how dying tumour cells, particularly those killed by chemotherapy, engage with antitumour immune responses. These data have significant implications for the development of new protocols combining chemotherapy with immunotherapy, indicating an exciting potential for therapeutic synergy with general applicability to many cancer types.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
